​

Immuneering (IMRX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Immuneering Revenue Highlights

00

Immuneering Revenue by Period

Immuneering Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31--100.00%
2022-12-31$316.95K-84.76%
2021-12-31$2.08M-10.02%
2020-12-31$2.31M20.41%
2019-12-31$1.92M-

Immuneering generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Immuneering Revenue by Quarter

DateRevenueChange
2025-03-31--100.00%
2024-12-31$726.33K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$-94.42M100.00%
2023-09-30--100.00%
2023-06-30$94.42M100.00%
2023-03-31--100.00%
2022-12-31$456.00-98.81%
2022-09-30$38.38K-59.35%
2022-06-30$94.42K-48.60%
2022-03-31$183.70K-3.11%
2021-12-31$189.59K-60.68%
2021-09-30$482.13K-26.95%
2021-06-30$660.04K-11.78%
2021-03-31$748.20K12.50%
2020-12-31$665.08K-2.56%
2020-09-30$682.57K41.96%
2020-06-30$480.83K-0.46%
2020-03-31$483.05K-

Immuneering generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Immuneering Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
GOSSGossamer Bio$114.70M$9.89M
GLUEMonte Rosa Therapeutics$75.62M$60.65M
NAMSNewAmsterdam Pharma$45.56M$12.77M
IVAInventiva$17.48M$2.73M
KRONKronos Bio$9.85M$2.27M
LYRALyra Therapeutics$1.53M$209.00K
IKNAIkena Oncology--
CGEMCullinan Oncology--
IMRXImmuneering--
ELVNEnliven Therapeutics--
CMPXCompass Therapeutics--
REPLReplimune Group--
NVCTNuvectis Pharma--
CNTACentessa Pharmaceuticals--
PMVPPMV Pharmaceuticals--
CELCCelcuity--
LRMRLarimar Therapeutics--

IMRX Revenue FAQ

What is Immuneering’s yearly revenue?

Immuneering's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. IMRX's yearly revenue for 2022 was $316.95K, representing a decrease of -84.76% compared to 2021.

What is Immuneering’s quarterly revenue?

Immuneering's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $726.33K, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023). IMRX's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023).

What is Immuneering’s revenue growth rate?

Immuneering's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.